Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments

Quteineh, L., Vandenberghe, F., Saigi Morgui, N., Delacrétaz, A., Choong, E., Gholam-rezaee, M., Magistretti, P., Bondolfi, G., Von Gunten, A., Preisig, M., Castelao, E., Vollenweider, P., Waeber, G., Bochud, M., Kutalik, Z., Conus, P., & Eap, C. B. (2015). Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments. Pharmacogenetics and Genomics, 25(5), 246-258. https://doi.org/10.1097/FPC.0000000000000131